Fall In Love With Xarelto Lawsuit

Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, have a duty to make sure that their drugs are reasonably secure for use - and failure to perform so could be grounds for compensation. Our lawyers are working tough to get those hurt by the drug the compensation they are entitled to.

Although bleeding can be a typical complication related with anticoagulants, it has been alleged that Xarelto is more dangerous than standard blood thinners simply because no antidote exists to reverse its blood-thinning effects. This implies that, in the occasion of an emergency, patients may possibly be at danger for irreversible bleeding issues, such as life-threatening internal and gastrointestinal hemorrhaging.

If you or even a loved one particular suffered a critical bleeding event following taking Xarelto, you may have legal recourse. For a lot more details, get in touch with us nowadays to have your case reviewed, free of charge of charge.
Compensation Possibilities

xarelto-compensation-photoThe plaintiffs in these lawsuits are in search of compensation from Bayer and Janssen for previous and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Additionally, they are searching for punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote http://xareltolaw.bitbucket.org/categories/Wyoming/Xarelto-Lawsuit-Lawyer-Rock-Springs-WY-82942.html available for Xarelto. Since of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, including cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.

In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:

The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.

Visit this page for much more info on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set

The attorneys in the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.